Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWGChandrajit P. Raut, Alessandro Gronchi, Dario Callegaro et al.|Clinical Cancer Research|2019Cited by 116
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumourSilvia Stacchiotti, Nadia Zaffaroni, Monica Tortoreto et al.|European Journal of Cancer|2014Cited by 67
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupWilliam W. Tseng, Jacek Skoczylas, Max L. Almond et al.|Annals of Surgical Oncology|2022Cited by 49
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)Carolyn Nessim, Guy Lahat, Chandrajit P. Raut et al.|Annals of Surgical Oncology|2021Cited by 41
Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Carolyn Nessim, Sanjay P. Bagaria, Chandrajit P. Raut et al.|Annals of Surgical Oncology|2021Cited by 40